SCOTT COLE MD
Prescription History 1346351004
Internal Medicine - Hematology & Oncology in Tulsa, OK
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SCOTT COLE MD, an active Hematology & Oncology specialist practicing in Tulsa, OK. Our medical registry currently tracks 54 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,622 documented patient claims. Among these therapy options, the most frequently utilized medication is Letrozole, which accounts for 462 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other OK PrescribersVs. OK Avg |
|---|---|---|---|
| Letrozole | 462 | $24.16▼ below OK avg | ▲ More than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 462 Medicare prescriptions for Letrozole, about 7.6 times the volume of the typical Oklahoma prescriber of this medication (60.7). Medicare paid an average of $24.16 per fill, versus $28.54 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 948.2 30-Day Fills standardized to 30-day supplies 28,420 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 127 | $14.19▼ below OK avg | ▲ More than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 127 Medicare prescriptions for Prochlorperazine Maleate, about 3.5 times the volume of the typical Oklahoma prescriber of this medication (36.4). Medicare paid an average of $14.19 per fill, versus $14.73 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 127 30-Day Fills standardized to 30-day supplies 1,297 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 119 | $8.17▼ below OK avg | ▲ More than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 119 Medicare prescriptions for Ondansetron Hcl, about 3.8 times the volume of the typical Oklahoma prescriber of this medication (31.6). Medicare paid an average of $8.17 per fill, versus $17.16 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 121 30-Day Fills standardized to 30-day supplies 1,299 Days of Medication total across all patients in 2024 | |||
| Exemestane | 97 | $89.07▼ below OK avg | ▲ More than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. A hormonal antineoplastic agent. In 2024, this provider wrote 97 Medicare prescriptions for Exemestane, about 2.6 times the volume of the typical Oklahoma prescriber of this medication (36.8). Medicare paid an average of $89.07 per fill, versus $119.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 159 30-Day Fills standardized to 30-day supplies 4,770 Days of Medication total across all patients in 2024 | |||
| Anastrozole | 94 | $37.42 | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 94 Medicare prescriptions for Anastrozole, about 1.5 times the volume of the typical Oklahoma prescriber of this medication (62.1). Medicare paid an average of $37.42 per fill, versus $23.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 203 30-Day Fills standardized to 30-day supplies 6,080 Days of Medication total across all patients in 2024 | |||
| Levothyroxine Sodium | 93 | $5.07▼ below OK avg | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 93 Medicare prescriptions for Levothyroxine Sodium, about half the volume of the typical Oklahoma prescriber of this medication (164.4). Medicare paid an average of $5.07 per fill, versus $9.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 141 30-Day Fills standardized to 30-day supplies 4,230 Days of Medication total across all patients in 2024 | |||
| Potassium Chloride | 85 | $11.67▼ below OK avg | ≈ Typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2024, this provider wrote 85 Medicare prescriptions for Potassium Chloride, about the same volume as the typical Oklahoma prescriber of this medication (88.9). Medicare paid an average of $11.67 per fill, versus $17.39 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 135 30-Day Fills standardized to 30-day supplies 3,895 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 80 | $678.53▼ below OK avg | ≈ Typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 80 Medicare prescriptions for Eliquis, about 81% of the volume of the typical Oklahoma prescriber of this medication (99.4). Medicare paid an average of $678.53 per fill, versus $789.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 94.3 30-Day Fills standardized to 30-day supplies 2,830 Days of Medication total across all patients in 2024 | |||
| Levofloxacin | 78 | $4.65▼ below OK avg | ▲ More than typical |
About Levofloxacin: Levofloxacin is used to treat a variety of bacterial infections. Show more ▾ This medication belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin. In 2024, this provider wrote 78 Medicare prescriptions for Levofloxacin, about 3 times the volume of the typical Oklahoma prescriber of this medication (26.1). Medicare paid an average of $4.65 per fill, versus $6.69 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 78 30-Day Fills standardized to 30-day supplies 592 Days of Medication total across all patients in 2024 | |||
| Oxycodone Hcl | 74 | $16.49▼ below OK avg | ≈ Typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 74 Medicare prescriptions for Oxycodone Hcl, about the same volume as the typical Oklahoma prescriber of this medication (79.2). Medicare paid an average of $16.49 per fill, versus $17.04 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 75.6 30-Day Fills standardized to 30-day supplies 1,340 Days of Medication total across all patients in 2024 | |||
| Tamoxifen Citrate | 68 | $26.44 | ▲ More than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 68 Medicare prescriptions for Tamoxifen Citrate, about 2.2 times the volume of the typical Oklahoma prescriber of this medication (30.9). Medicare paid an average of $26.44 per fill, versus $26.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 135.7 30-Day Fills standardized to 30-day supplies 4,070 Days of Medication total across all patients in 2024 | |||
| Hydroxyurea | 67 | $23.35 | ▲ More than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2024, this provider wrote 67 Medicare prescriptions for Hydroxyurea, about 1.7 times the volume of the typical Oklahoma prescriber of this medication (38.6). Medicare paid an average of $23.35 per fill, versus $23.31 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 101.7 30-Day Fills standardized to 30-day supplies 3,019 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 64 | $22.79 | ▲ More than typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 64 Medicare prescriptions for Ondansetron Odt, about 2.1 times the volume of the typical Oklahoma prescriber of this medication (30.3). Medicare paid an average of $22.79 per fill, versus $17.90 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 64 30-Day Fills standardized to 30-day supplies 1,112 Days of Medication total across all patients in 2024 | |||
| CabometyxCabozantinib S-Malate | 60 | $20,687.08▼ below OK avg | ▲ More than typical |
About Cabometyx: This medication is used to treat various types of cancer (including kidney, thyroid, liver cancer). Show more ▾ Cabozantinib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2024, this provider wrote 60 Medicare prescriptions for Cabometyx, about 2 times the volume of the typical Oklahoma prescriber of this medication (30.4). Medicare paid an average of $20,687.08 per fill, versus $24,398.99 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 60 30-Day Fills standardized to 30-day supplies 1,788 Days of Medication total across all patients in 2024 | |||
| Olanzapine | 58 | $9.85▼ below OK avg | ≈ Typical |
About Olanzapine: This medication is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder). Show more ▾ It may also be used in combination with other medication to treat depression. Olanzapine belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used by teenagers). See also Precautions section. A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. In 2024, this provider wrote 58 Medicare prescriptions for Olanzapine, about the same volume as the typical Oklahoma prescriber of this medication (54.7). Medicare paid an average of $9.85 per fill, versus $23.27 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 80 30-Day Fills standardized to 30-day supplies 2,291 Days of Medication total across all patients in 2024 | |||
| IbrancePalbociclib | 57 | $15,943.99 | ▲ More than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Has antineoplastic activity; specific inhibitor of cyclin-dependent kinases 4 & 6. In 2024, this provider wrote 57 Medicare prescriptions for Ibrance, about 1.7 times the volume of the typical Oklahoma prescriber of this medication (32.7). Medicare paid an average of $15,943.99 per fill, versus $15,264.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57 30-Day Fills standardized to 30-day supplies 1,596 Days of Medication total across all patients in 2024 | |||
| Lidocaine-PrilocaineLidocaine/Prilocaine | 53 | $11.66▼ below OK avg | ▲ More than typical |
About Lidocaine-Prilocaine: This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. Show more ▾ It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts). A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION. In 2024, this provider wrote 53 Medicare prescriptions for Lidocaine-Prilocaine, about 2.2 times the volume of the typical Oklahoma prescriber of this medication (24). Medicare paid an average of $11.66 per fill, versus $16.17 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 53 30-Day Fills standardized to 30-day supplies 1,509 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 43 | $12.63▼ below OK avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 43 Medicare prescriptions for Gabapentin, about a third of the volume of the typical Oklahoma prescriber of this medication (114.8). Medicare paid an average of $12.63 per fill, versus $16.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 61.8 30-Day Fills standardized to 30-day supplies 1,840 Days of Medication total across all patients in 2024 | |||
| Prednisone | 42 | $6.27 | ≈ Typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 42 Medicare prescriptions for Prednisone, about the same volume as the typical Oklahoma prescriber of this medication (45.6). Medicare paid an average of $6.27 per fill, versus $3.46 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 46.8 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| KisqaliRibociclib Succinate | 42 | $16,417.25 | ▲ More than typical |
About Kisqali: Ribociclib is used to treat breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Inhibits both CDK4 and CDK6. In 2024, this provider wrote 42 Medicare prescriptions for Kisqali, about 1.8 times the volume of the typical Oklahoma prescriber of this medication (23.4). Medicare paid an average of $16,417.25 per fill, versus $14,179.08 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42 30-Day Fills standardized to 30-day supplies 1,176 Days of Medication total across all patients in 2024 | |||
| Imatinib Mesylate | 41 | $542.34▼ below OK avg | ▲ More than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2024, this provider wrote 41 Medicare prescriptions for Imatinib Mesylate, about 1.6 times the volume of the typical Oklahoma prescriber of this medication (25.5). Medicare paid an average of $542.34 per fill, versus $1,356.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 41 30-Day Fills standardized to 30-day supplies 1,230 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 40 | $18.33 | ▲ More than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 40 Medicare prescriptions for Dexamethasone, about 1.3 times the volume of the typical Oklahoma prescriber of this medication (29.8). Medicare paid an average of $18.33 per fill, versus $12.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49.1 30-Day Fills standardized to 30-day supplies 946 Days of Medication total across all patients in 2024 | |||
| InlytaAxitinib | 40 | $18,460.75 | ≈ Typical |
About Inlyta: This medication is used to treat kidney cancer. Show more ▾ Axitinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as tyrosine kinase inhibitors. A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA. In 2024, this provider wrote 40 Medicare prescriptions for Inlyta, about the same volume as the typical Oklahoma prescriber of this medication (41.6). Medicare paid an average of $18,460.75 per fill, versus $17,983.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40 30-Day Fills standardized to 30-day supplies 1,200 Days of Medication total across all patients in 2024 | |||
| Pantoprazole Sodium | 39 | $23.35 | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2024, this provider wrote 39 Medicare prescriptions for Pantoprazole Sodium, about half the volume of the typical Oklahoma prescriber of this medication (91.8). Medicare paid an average of $23.35 per fill, versus $16.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 94 30-Day Fills standardized to 30-day supplies 2,804 Days of Medication total across all patients in 2024 | |||
| ImbruvicaIbrutinib | 39 | $20,370.80 | ≈ Typical |
About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor. In 2024, this provider wrote 39 Medicare prescriptions for Imbruvica, about 1.2 times the volume of the typical Oklahoma prescriber of this medication (31.7). Medicare paid an average of $20,370.80 per fill, versus $15,948.66 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,092 Days of Medication total across all patients in 2024 | |||
| Acyclovir | 37 | $16.14 | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2024, this provider wrote 37 Medicare prescriptions for Acyclovir, about 1.6 times the volume of the typical Oklahoma prescriber of this medication (23.7). Medicare paid an average of $16.14 per fill, versus $15.29 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 61 30-Day Fills standardized to 30-day supplies 1,820 Days of Medication total across all patients in 2024 | |||
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $26.84 | ▼ Less than typical |
About Hydrocodone-Acetaminophen: This combination medication is used to relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2024, this provider wrote 35 Medicare prescriptions for Hydrocodone-Acetaminophen, about a quarter of the volume of the typical Oklahoma prescriber of this medication (138.7). Medicare paid an average of $26.84 per fill, versus $24.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 560 Days of Medication total across all patients in 2024 | |||
| CalquenceAcalabrutinib Maleate | 34 | $12,342.03▼ below OK avg | ▲ More than typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Inhibits Bruton’s tyrosine kinase; has antineoplastic activity. In 2024, this provider wrote 34 Medicare prescriptions for Calquence, about 1.3 times the volume of the typical Oklahoma prescriber of this medication (26.2). Medicare paid an average of $12,342.03 per fill, versus $13,967.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2024 | |||
| Mirtazapine | 31 | $16.48▼ below OK avg | ▼ Less than typical |
About Mirtazapine: This medication is used to treat depression. Show more ▾ Mirtazapine works by helping to restore the balance of certain natural substances in the brain. A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders. In 2024, this provider wrote 31 Medicare prescriptions for Mirtazapine, about 65% of the volume of the typical Oklahoma prescriber of this medication (48). Medicare paid an average of $16.48 per fill, versus $18.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2024 | |||
| XareltoRivaroxaban | 28 | $733.15▼ below OK avg | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2024, this provider wrote 28 Medicare prescriptions for Xarelto, about 63% of the volume of the typical Oklahoma prescriber of this medication (44.6). Medicare paid an average of $733.15 per fill, versus $857.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2024 | |||
| Alendronate Sodium | 26 | $14.98 | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2024, this provider wrote 26 Medicare prescriptions for Alendronate Sodium, about half the volume of the typical Oklahoma prescriber of this medication (45.5). Medicare paid an average of $14.98 per fill, versus $10.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 67.6 30-Day Fills standardized to 30-day supplies 2,022 Days of Medication total across all patients in 2024 | |||
| VerzenioAbemaciclib | 25 | $17,149.18 | ≈ Typical |
About Verzenio: This medication is used to treat certain types of breast cancer. Show more ▾ Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. A cell cycle inhibitor. In 2024, this provider wrote 25 Medicare prescriptions for Verzenio, about the same volume as the typical Oklahoma prescriber of this medication (24.3). Medicare paid an average of $17,149.18 per fill, versus $15,203.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 700 Days of Medication total across all patients in 2024 | |||
| FruzaqlaFruquintinib | 23 | $23,895.70 | – No State Data |
About Fruzaqla: This medication is used to treat cancer of the colon and rectum. Show more ▾ Fruquintinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. A VEGF receptor antagonist. In 2024, this provider wrote 23 Medicare prescriptions for Fruzaqla. Medicare paid an average of $23,895.70 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $23,895.70 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 644 Days of Medication total across all patients in 2024 | |||
| Morphine Sulfate ErMorphine Sulfate | 22 | $22.83▼ below OK avg | ▼ Less than typical |
About Morphine Sulfate Er: This medication is used to help relieve severe ongoing pain (such as due to cancer). Show more ▾ Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (100 milligrams or more per tablet) should be used only if you have been regularly taking moderate to large amounts of opioid pain medications. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of morphine to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use. The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. In 2024, this provider wrote 22 Medicare prescriptions for Morphine Sulfate Er, about a third of the volume of the typical Oklahoma prescriber of this medication (75.5). Medicare paid an average of $22.83 per fill, versus $29.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 22 30-Day Fills standardized to 30-day supplies 628 Days of Medication total across all patients in 2024 | |||
| Omeprazole | 21 | $8.81▼ below OK avg | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2024, this provider wrote 21 Medicare prescriptions for Omeprazole, about 20% of the volume of the typical Oklahoma prescriber of this medication (106.8). Medicare paid an average of $8.81 per fill, versus $18.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2024 | |||
| Megestrol Acetate | 19 | $41.75▼ below OK avg | ≈ Typical |
About Megestrol Acetate: Megestrol is used to treat loss of appetite and weight loss in people with AIDS. Show more ▾ Improving your appetite and gaining weight may help you feel better and be more active. Megestrol is similar to a natural substance made by the body called progesterone. Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2024, this provider wrote 19 Medicare prescriptions for Megestrol Acetate, about 76% of the volume of the typical Oklahoma prescriber of this medication (24.9). Medicare paid an average of $41.75 per fill, versus $54.94 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 19 30-Day Fills standardized to 30-day supplies 534 Days of Medication total across all patients in 2024 | |||
| Allopurinol | 18 | $6.33▼ below OK avg | ▼ Less than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2024, this provider wrote 18 Medicare prescriptions for Allopurinol, about a third of the volume of the typical Oklahoma prescriber of this medication (51.4). Medicare paid an average of $6.33 per fill, versus $10.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| TagrissoOsimertinib Mesylate | 18 | $15,833.14▼ below OK avg | ≈ Typical |
About Tagrisso: This medication is used to treat lung cancer. Show more ▾ Osimertinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors. An EGFR tyrosine kinase inhibitor. In 2024, this provider wrote 18 Medicare prescriptions for Tagrisso, about 81% of the volume of the typical Oklahoma prescriber of this medication (22.3). Medicare paid an average of $15,833.14 per fill, versus $16,162.34 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2024 | |||
| Tramadol Hcl | 18 | $5.25▼ below OK avg | ▼ Less than typical |
About Tramadol Hcl: See also Warning section. Show more ▾ This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A narcotic analgesic proposed for severe pain. It may be habituating. In 2024, this provider wrote 18 Medicare prescriptions for Tramadol Hcl, about a third of the volume of the typical Oklahoma prescriber of this medication (63.5). Medicare paid an average of $5.25 per fill, versus $9.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 18 30-Day Fills standardized to 30-day supplies 314 Days of Medication total across all patients in 2024 | |||
| Spironolactone | 17 | $15.65 | ▼ Less than typical |
About Spironolactone: Spironolactone is used to treat high blood pressure and heart failure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a "water pill" (potassium-sparing diuretic). A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) In 2024, this provider wrote 17 Medicare prescriptions for Spironolactone, about a third of the volume of the typical Oklahoma prescriber of this medication (49.1). Medicare paid an average of $15.65 per fill, versus $9.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 690 Days of Medication total across all patients in 2024 | |||
| Fentanyl | 16 | $114.09 | ▼ Less than typical |
About Fentanyl: This medication is used to help relieve severe ongoing pain (such as due to cancer). Show more ▾ Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use the patch form of fentanyl to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use. A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078) In 2024, this provider wrote 16 Medicare prescriptions for Fentanyl, about half the volume of the typical Oklahoma prescriber of this medication (33.9). Medicare paid an average of $114.09 per fill, versus $107.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 459 Days of Medication total across all patients in 2024 | |||
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 16 | $14.79▼ below OK avg | ≈ Typical |
About Diphenoxylate-Atropine: This medication is used to treat diarrhea. Show more ▾ It helps to decrease the number and frequency of bowel movements. It works by slowing the movement of the intestines. Diphenoxylate is similar to opioid pain relievers, but it acts mainly to slow the gut. Atropine belongs to a class of drugs known as anticholinergics, which help to dry up body fluids and also slow gut movement. This medication should not be used to treat diarrhea caused by certain types of infection (such as C. difficile-associated diarrhea following antibiotic therapy). Talk to your doctor for more details. This medication is not recommended for use in children younger than 6 years due to an increased risk of serious side effects (such as breathing problems). In 2024, this provider wrote 16 Medicare prescriptions for Diphenoxylate-Atropine, about 83% of the volume of the typical Oklahoma prescriber of this medication (19.2). Medicare paid an average of $14.79 per fill, versus $20.69 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 16.7 30-Day Fills standardized to 30-day supplies 174 Days of Medication total across all patients in 2024 | |||
| Furosemide | 15 | $4.48▼ below OK avg | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a "water pill" (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2024, this provider wrote 15 Medicare prescriptions for Furosemide, about 16% of the volume of the typical Oklahoma prescriber of this medication (94.6). Medicare paid an average of $4.48 per fill, versus $5.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 15 30-Day Fills standardized to 30-day supplies 317 Days of Medication total across all patients in 2024 | |||
| Lenalidomide | 15 | $16,108.54 | ▼ Less than typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 15 Medicare prescriptions for Lenalidomide, about half the volume of the typical Oklahoma prescriber of this medication (31.3). Medicare paid an average of $16,108.54 per fill, versus $13,305.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 406 Days of Medication total across all patients in 2024 | |||
| Everolimus | 14 | $4,916.87 | ▼ Less than typical |
About Everolimus: Everolimus is used to treat various types of cancer (such as kidney, breast, pancreas, lung, stomach/intestinal cancers). Show more ▾ Everolimus is also used in people with a certain genetic disorder (tuberous sclerosis complex) to treat certain types of benign tumors in the brain or kidney. It works by slowing or stopping the growth of cancer or tumor cells. A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT. In 2024, this provider wrote 14 Medicare prescriptions for Everolimus, about 67% of the volume of the typical Oklahoma prescriber of this medication (21). Medicare paid an average of $4,916.87 per fill, versus $2,680.30 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2024 | |||
| LynparzaOlaparib | 14 | $16,458.77 | ≈ Typical |
About Lynparza: This medication is used to treat certain cancers (such as breast, ovarian, fallopian tube, pancreatic, peritoneal cancer, prostate). Show more ▾ Olaparib works by slowing or stopping the growth of cancer cells. An antineoplastic agent, Poly(ADP-ribose) Polymerase inhibitor. In 2024, this provider wrote 14 Medicare prescriptions for Lynparza, about the same volume as the typical Oklahoma prescriber of this medication (15.4). Medicare paid an average of $16,458.77 per fill, versus $13,395.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| JakafiRuxolitinib Phosphate | 14 | $16,732.15 | ▼ Less than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2024, this provider wrote 14 Medicare prescriptions for Jakafi, about half the volume of the typical Oklahoma prescriber of this medication (26.5). Medicare paid an average of $16,732.15 per fill, versus $16,367.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 405 Days of Medication total across all patients in 2024 | |||
| TukysaTucatinib | 13 | $26,656.09 | – No State Data |
About Tukysa: This medication is used to treat certain types of breast, colon, or rectum cancers. Show more ▾ Tucatinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Receptor tyrosine kinase inhibitor for tratment of HER2 positive breast cancer. In 2024, this provider wrote 13 Medicare prescriptions for Tukysa. Medicare paid an average of $26,656.09 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $26,656.09 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| RevlimidLenalidomide | 13 | $18,141.79 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 13 Medicare prescriptions for Revlimid, about a third of the volume of the typical Oklahoma prescriber of this medication (35.9). Medicare paid an average of $18,141.79 per fill, versus $17,282.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
| LenvimaLenvatinib Mesylate | 12 | $23,380.96▼ below OK avg | ≈ Typical |
About Lenvima: This medication is used to treat cancer. Show more ▾ Lenvatinib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2024, this provider wrote 12 Medicare prescriptions for Lenvima, about 80% of the volume of the typical Oklahoma prescriber of this medication (15). Medicare paid an average of $23,380.96 per fill, versus $24,143.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 12 30-Day Fills standardized to 30-day supplies 345 Days of Medication total across all patients in 2024 | |||
| OxycontinOxycodone Hcl | 12 | $471.06▼ below OK avg | ▼ Less than typical |
About Oxycontin: This medication is used to help relieve severe ongoing pain (such as due to cancer). Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (more than 40 milligrams per tablet) should be used only if you have been regularly taking moderate to large amounts of an opioid pain medication. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of oxycodone to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 12 Medicare prescriptions for Oxycontin, about a third of the volume of the typical Oklahoma prescriber of this medication (33). Medicare paid an average of $471.06 per fill, versus $627.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 12 30-Day Fills standardized to 30-day supplies 347 Days of Medication total across all patients in 2024 | |||
| LorbrenaLorlatinib | 12 | $20,077.95 | – No State Data |
About Lorbrena: Lorlatinib is used to treat a certain type of lung cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Inhibits both anaplastic lymphoma kinase and c-ros oncogene 1 (ROS1) protein. In 2024, this provider wrote 12 Medicare prescriptions for Lorbrena. Medicare paid an average of $20,077.95 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $20,077.95 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Escitalopram Oxalate | 11 | $16.05 | ▼ Less than typical |
About Escitalopram Oxalate: This medication is used to treat certain mental/mood disorders (such as depression, anxiety). Show more ▾ Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder. In 2024, this provider wrote 11 Medicare prescriptions for Escitalopram Oxalate, about 18% of the volume of the typical Oklahoma prescriber of this medication (59.6). Medicare paid an average of $16.05 per fill, versus $12.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2024 | |||
| XtandiEnzalutamide | 11 | $13,472.52 | ▼ Less than typical |
About Xtandi: Enzalutamide is used to treat prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. An antineoplastic agent. In 2024, this provider wrote 11 Medicare prescriptions for Xtandi, about a third of the volume of the typical Oklahoma prescriber of this medication (38). Medicare paid an average of $13,472.52 per fill, versus $13,383.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for SCOTT COLE MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Tulsa, OK practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OK prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
